Healthcare stocks face gridlock as pharma prices outpace tech for first time in 20 years
Gridlock in Washington could stall healthcare policy, leaving drugmakers unusually expensive compared to technology while medical equipment sits at lows.
Pick the topics you care about. Your homepage shows them first. No account needed.
Get new stories on your phone
Gridlock in Washington could stall healthcare policy, leaving drugmakers unusually expensive compared to technology while medical equipment sits at lows.